Efficacy of cutting balloon angioplasty versus high-pressure balloon angioplasty for the treatment of arteriovenous fistula stenoses in patients undergoing hemodialysis: Systematic review and meta-analysis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0296191 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS ONE, 2024. Verfasst von Shuyue Pang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun Jilin, China. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Angioplasty, Balloon, Arteriovenous Fistula. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Traditional Chinese Medicine Evidence Based Ability Enhancement Project 2023.
Abstract (Originalsprache)
This systematic review and meta-analysis aimed to assess and compare the therapeutic outcomes of cutting balloon angioplasty and high-pressure balloon angioplasty for arteriovenous fistula stenosis in hemodialysis patients. All studies indexed in PubMed, Embase, and Cochrane Library Web of Science were retrieved. The retrieval deadline was July 15, 2023. Risk of bias 2.0 was used to evaluate the quality of the included studies. Revman 5.4 software was used for data analysis. This review included three studies and 180 patients, with 90 patients in the cutting balloon angioplasty group and 90 patients in the high-pressure balloon angioplasty group. The results of the meta-analysis suggested that compared with high-pressure balloon angioplasty, cutting balloon angioplasty can improve primary lesion patency rates of internal arteriovenous fistulas at 6 months (relative risk, 1.45; 95% confidence interval, 1.08–1.96; P = 0.01). However, there were no significant differences between the technical success rate (relative risk, 0.99; 95% confidence interval, 0.93–1.05; P = 0.72) and clinical success rate (relative risk, 1.01; 95% confidence interval, 0.95–1.07; P = 0.73). Therefore, cutting balloon angioplasty is likely to increase primary lesion patency rates at 6 months. However, more high-quality, large-sample, multicenter, randomized controlled trials are needed for further validation due to the limited number of included studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun Jilin, China.
- EBM Office, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun Jilin, China.
- Nephrology Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun Jilin, China.
ORCID-Profile: Shuyue Pang, Shoulin Zhang
Förderung
- Traditional Chinese Medicine Evidence Based Ability Enhancement Project 2023
Zitieren
APA
Pang, S., Chang, T., Chang, M., Huang, X., Wang, X., Song, M., Wang, Z., & Zhang, S. (2024). Efficacy of cutting balloon angioplasty versus high-pressure balloon angioplasty for the treatment of arteriovenous fistula stenoses in patients undergoing hemodialysis: Systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0296191
Vancouver
Pang S, Chang T, Chang M, Huang X, Wang X, Song M, et al. Efficacy of cutting balloon angioplasty versus high-pressure balloon angioplasty for the treatment of arteriovenous fistula stenoses in patients undergoing hemodialysis: Systematic review and meta-analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0296191
BibTeX
@article{Pang2024,
author = {Pang, Shuyue and Chang, Tianying and Chang, Mingxin and Huang, Xu and Wang, Xiaodan and Song, Meijin and Wang, Zhongtian and Zhang, Shoulin},
title = {Efficacy of cutting balloon angioplasty versus high-pressure balloon angioplasty for the treatment of arteriovenous fistula stenoses in patients undergoing hemodialysis: Systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0296191}
}
EUVIMED